tiprankstipranks
Trending News
More News >

GB:CURE ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
13Bullish
1Neutral
8Bearish
Oscillators
Sell
4Bullish
1Neutral
5Bearish
Moving Averages
Buy
9Bullish
0Neutral
3Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is 0.23, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 18.03, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 18.17, making it a Buy.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

May 14, 2025, 09:26 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
18.52
18.50
18.59
18.58
18.67
18.65
18.74
Fibonacci
18.50
18.53
18.55
18.58
18.60
18.62
18.65

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

May 14, 2025, 09:26 AM
Period
Simple
Exponential
MA5
18.40Buy
18.51Buy
MA10
18.33Buy
18.30Buy
MA20
17.82Buy
18.03Buy
MA50
17.99Buy
18.17Buy
MA100
18.90Sell
18.63Buy
MA200
19.29Sell
18.98Sell
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 18.30, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 18.63, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 17.99, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 18.90, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 19.29, creating a Sell signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

May 14, 2025, 09:26 AM
Name
Value
Action
RSI (14)
61.77
Neutral
STOCH (9,6)
84.06
Sell
STOCHRSI (14)
92.91
Sell
MACD (12,26)
0.23
Sell
ADX (14)
17.77
Buy
Williams %R
-0.35
Sell
CCI (14)
125.78
Sell
ATR (14)
0.25
-
Ultimate Oscillator
71.72
Buy
ROC
9.50
Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 61.77, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 17.77, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is 125.78, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is 9.50, creating a Buy signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Buy.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 61.77, which suggests CURE is a Neutral.
      What is CURE’s MACD?
      CURE’s MACD is 0.23, which suggests CURE is a Sell.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 18.40, which suggests CURE is a Buy.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 17.82, which suggests CURE is a Buy.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 17.99, which suggests CURE is a Buy.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 19.29, which suggests CURE is a Sell.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is -0.35, which suggests CURE is a Sell.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is 125.78, which suggests CURE is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis